A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Clinical trial NCT06398405 · UNKNOWN

Trial details

NCT number: NCT06398405
Sponsor: Shandong Cancer Hospital and Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Dysphagia, Esophageal Epigallocatechin Gallate

Start date: 2024-04-22
Primary completion: 2026-04-22
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.